AGEN Agenus Inc
$7.32
Agenus Inc (AGEN) Earnings News
Earnings press releases and Earnings Whispers previews for Agenus Inc (AGEN), newest first.
Thursday
August 6, 2026
7:30 AM ET
Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer
Tuesday
July 28, 2026
4:30 PM ET
Agenus to Provide Second Quarter 2026 Financial Report and Development Update
Monday
May 11, 2026
8:45 AM ET
Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
Monday
May 4, 2026
4:30 PM ET
Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
Monday
March 16, 2026
7:30 AM ET
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
Wednesday
March 4, 2026
4:30 PM ET
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update